medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2018, Number 1

<< Back Next >>

Rev Mex Anest 2018; 41 (1)

Descriptive study of anesthetic management in brachytherapy of the cervix

Catalá-Ripoll JV, Torres-Valiño C, Cuesta-Montero P, Solís-Navarro I

Language: Spanish
References: 12
Page: 15-17
PDF size: 147.12 Kb.


ABSTRACT

Introduction: Brachytherapy is an appropriate therapeutic option in cervical cancer. Due to its realization in areas outside the operating room and ambulatory character, needs proper anesthetic management. For it has been commonly used locoregional anesthesia and sedations. Material and methods: Observational, retrospective and descriptive study of brachytherapy presence of anesthetist performed in 2014 at the University General Hospital of Albacete. Results: Data were collected from 18 patients with a mean age of 50.47 years. 86 sessions which are collected. 87% of patients performed five sessions. 83% of the first sessions were performed with spinal anesthesia. In a total of eight cases locoregional anesthesia was performed in all sessions, while none of the patients sedation was performed in all sessions. In 84% of cases of spinal anesthetic combination of bupivacaine 0.5% and 4 mg Fentanyl 25 µg was used. As sedations were made variably propofol infusion or bolus propofol associated both fentanyl as remifentanil. Conclusions: In our opinion the techniques of locoregional anesthesia represent an advance compared with conscious sedation due to better management of the airway in areas outside the operating room with a low incidence of complications and good control of both analgesic and the patient immobilization.


REFERENCES

  1. Torre A, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 62015;5:87-108.

  2. Smith MD, Todd JG, Symonds RP. Analgesia for pelvic brachytherapy. Br J Anaesth. 2002;88:270-276.

  3. Orton CG. High and low dose-rate brachytherapy for cervical carcinoma. Acta Oncol. 1998;37:117-125.

  4. Mille-Loera JE, Hernández-Zúñiga S. Manejo anestésico para procedimientos fuera del quirófano. Rev Mex Anest. 2007;30:202-207.

  5. De Buck F, Devroe S, Missant C, Van de Velde M. Regional anesthesia outside the operating room: indications and techniques. Curr Opin Anaesthesiol. 2012;25:501-507.

  6. Janaki MG, Nirmala S, Kadam AR, Ramesh BS, Sunitha KS. Epidural analgesia during brachytherapy for cervical cancer patients. J Cancer Res Ther. 2008;4:60-63.

  7. Bhanabhai H, Samant R, EC, Grenier L, Lowry S. Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy. Curr Oncol. 2013;20:e307-310.

  8. Nguyen C, Souhami L, Roman TN, Clark BG. High-dose-rate brachytherapy as the primary treatment of medically inoperable stage I-II endometrial carcinoma. Gynecol Oncol. 1995;59:370-375.

  9. Lanciano R, Corn B, Martin E, Scultheiss T, Hogan WM, Rosenblum N. Perioperative morbidity of intracavitary gynaecologic brachytherapy. Int J Radiat Oncol Biol Phys. 1994;29:969-74.

  10. Oei-Lim VL, Kalkman CJ, van Tienhoven G, Engbers FH. Remote controlled prolonged conscious sedation for gynaecological radiotherapy. Anaesthesia. 1996;51:866-868.

  11. Nguyen TV, Petereit DG. High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer. Gynecol Oncol. 1998;71:196-203.

  12. Montgomery JE, Sutherland CJ, Kestin IG, Sneyd JR. Morphine consumption in patients receiving rectal paracetamol and diclofenac alone and in combination. Br J Anaesth. 1996;77:445-447.




2020     |     www.medigraphic.com